Skip to main content
EJNMMI Research

Table 2 Comparison of FDG accumulation and intratumoral distribution between responders and non-responders

From: Heterogeneity of intratumoral 111In-ibritumomab tiuxetan and 18F-FDG distribution in association with therapeutic response in radioimmunotherapy for B-cell non-Hodgkin’s lymphoma

 

Responder ( n  = 26)

Non-responder ( n  = 16)

p value

SUVmax

4.8 ± 2.0

8.5 ± 4.7

<0.05

Skewness

1.07 ± 0.29

1.17 ± 0.40

n. s.

Kurtosis

3.56 ± 0.91

3.99 ± 1.34

n. s.

AUC-CSH

0.30 ± 0.05

0.30 ± 0.06

n. s.

  1. n. s., not significant.
Back to article page